Showing results (191-200 of 209) with videos related to
Sort By:
Pageof 21
Frontiers in Oncology|November 2, 2020
Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective StudyHyung Suk Kim, Won Sik Jang, Won Sik Ham, et al.Cancers|May 28, 2022
Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell CarcinomaByulA Jee, Eunjeong Seo, Kyunghee Park, et al.Investigative and Clinical Urology|May 1, 2026
Association of initial transurethral resection staging on survival in radical cystectomy patientsJoongwon Choi, Wan Song, Jong Kil Nam, et al.Cancer Research and Treatment|May 15, 2025
Real-world Efficacy of Intravesical Gemcitabine for BCG-Unresponsive Non-Muscle-Invasive Bladder CancerHye Won Lee, Eui Hyun Jung, Kyung Hwan Kim, et al.World Journal of Gastroenterology|May 17, 2016
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrenceAlice Tung Wan Song, Rodolphe Sobesky, Carmen Vinaixa, et al.Journal of Robotic Surgery|September 12, 2025
Demonstrating the non-inferiority of robotic radical cystectomy for cT3-cT4 urothelial carcinoma in the era of neoadjuvant chemotherapy: a propensity score-matched analysisIl Woo Park, Tae Il Noh, Seok Ho Kang, et al.Proceedings of the National Academy of Sciences of the United States of America|July 23, 2013
Targeting H3K4 trimethylation in Huntington diseaseMalini Vashishtha, Christopher W Ng, Ferah Yildirim, et al.Frontiers in Oncology|May 16, 2022
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell CarcinomaHyunji Jo, Joohyun Hong, Hongsik Kim, et al.Scientific Reports|February 27, 2024
Survival pattern of metastatic renal cell carcinoma patients according to WHO/ISUP grade: a long-term multi-institutional studyJoongwon Choi, Seokhwan Bang, Jungyo Suh, et al.Cell Reports|September 2, 2023
TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradationQianjin Guo, Zi-Ming Cheng, Hector Gonzalez-Cantú, et al.Pageof 21